Note

December 02, 20 - 6:08 pm - LABS

Brazil’s health regulator Anvisa sets conditions for approving COVID-19 vaccines

Brazil’s health regulator Anvisa announced on Wednesday, during a press conference, a set of requirements for approving COVID-19 vaccines for emergency use in the country.

The document, which follows the example of other international bodies, was created to be distributed to laboratories informing which procedures are necessary to guarantee special approval for experimental immunizers.

The regulator said vaccine authorizations will be analyzed case-by-case and laboratories will still have to follow usual registration for the vaccines. Anvisa informed that in order to get emergency approval, all vaccines need to be in phase 3 of trials.